IRCT2013030912762N1已完成未知
The effect of calcitriol on progress and activity of Lupus nephritis
Vice- Chancellorship for Research, Guilan University of Medical Sciences, Iran0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years(—)
- 性别
- All
入选标准
- •Inclusion Criteria:
- •aged 18-65 years; baseline SLEDAI score <= 4; estimated glomerular filtration rate more than 15 ml/min/1.73m2; proteinuria > 1 g/day (or proteinuria > 1 g/g-Cr) in 2 consecutive samples within 12 weeks despite ACE inhibitor at least 3 months; on maintenance dose of prednisolone < 15 mg/day, with or without other immunosuppressive medications; serum calcium level in normal range( 8.5-10.5 mg/dl); history of biopsy-proven lupus nephritis clinical quiescent SLE for at least 3 month; willingness to give written consent and comply with the study protocol;
排除标准
- •Pregnancy, lactating or childbearing potential without effective method of birth control; Severe gastrointestinal disorders that interfere with their ability to receive or absorb oral medication; History of malignancy, including leukemia and lymphoma within the past 2 years; Systemic infection requiring therapy at study entry; Any other severe coexisting disease such as, but not limited to, chronic liver disease, myocardial infarction, cerebrovascular accident, malignant hypertension; History of drug or alcohol abuse within past 2 years; Vitamin D deficiency(25 hydroxy vitamin D less than 20ng/ml); Participation in any previous trial on vitamin D analogue; Patients receiving treatment of vitamin D and/or its analogue for other medical reasons within the past 4 weeks; Patients who are taking multivitamin supplement that contains vitamin D could be enrolled after 4 weeks of wash out period by changing to a preparation that has no vitamin D; On other investigational drugs within last 30 days; History of a psychological illness or condition such as to interfere with the patient's ability to understand the requirement of the study; History of non-compliance; Known history of sensitivity or allergy to vitamin D analogs
研究者
相似试验
招募中
3 期
Calcitriol supplementation in Nonalcoholic Fatty Liver Diseaseon-Alcoholic Fatty Liver disease (NAFLD).Fatty (change of) liver, not elsewhere classifiedIRCT2017053034222N1Ahvaz Jundishapur University of Medical Sciences160
已完成
3 期
Effect of Calciterol and Cinacalcate on hyperparathyroidismIRCT20190702044076N1Shahre-kord University of Medical Sciences60
已完成
2 期
Effects of calcitriol on the complications of hematopoietic stem cell transplantatioHodgkin lymphomaCondition 1: Hodgkin lymphoma. Condition 2: Non-Hodgkin lymphoma. Condition 3: Multiple myeloma.Follicular lymphoma, Non-follicular lymphoma, Mature T/NK-cell lymphomas, Other and unspecified types of non-Hodgkin lymphomaMultiple myeloma and malignant plasma cell neoplasmsC82, C83,IRCT2016052727435N2Research Center of the Hematology and Oncology and Stem Cell Transplantation, Shariati Hospital80
已完成
2 期
Evaluation of the effect of calcitriol supplementation on diabetes control and its complications in hyperlipidemic patients with type 2 diabetes mellitus, Shiraz, 2009IRCT138806282480N1Shiraz university of medical sciences70
Unknown
2 期
The Effect of Calcitriol on Progress and Activity of Lupus NephritisSystemic Lupus ErythematosusNCT01863641Guilan University of Medical Sciences50
